The National Football League (NFL) has awarded $1 million in research funding to two teams of medical researchers at the University of California and University of Regina.
In a release, the NFL said the studies will research “the effects of cannabinoids on pain management and neuroprotection from concussion in elite football players.”
“The specific goal of this project is to determine whether cannabis/hemp based cannabinoids, i.e., cannabidiol (CBD) and tetrahydrocannabinol (THC), can be used safely and effectively for pain management and to reduce the use of prescription medications including opioids in post-concussion syndrome athletes,” the statement added.
Read more: Can CBD treat COVID-19? Clinical trials still needed, researchers warn
NFL chief medical officer, Dr. Allen Sills said the league wants to make sure that players are receiving care reflective of the most-up-to-date medical consensus.
Story continues below advertisement
“While the burden of proof is
